A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.


Updates from The Motley Fool

Latest updates on Arrowhead Pharmaceuticals from Fool.com.
3 Top Stocks Under $10

Image source: Getty Images One of the most common mistakes that new investors make is to only buy...



Stock Performance

View Interactive ARWR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arrowhead Pharmaceuticals.
Current Price: $1.37
Prev Close: $1.37
Open: $1.38
Bid: $1.34
Ask: $1.35
Day's Range: $1.34 - $1.40
52wk Range: $1.32 - $8.22
Volume: 1,233,169
Avg Vol 2,265,412
Market Cap: $82M
P/E (ttm): -0.98
EPS (ttm): ($1.41)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arrowhead Pharmaceuticals.
CAPS Rating 4 out of 5
 
205 Outperform
14 Underperform
CAPS All Stars
 
34 Outperform
8 Underperform

How do you think Arrowhead Pharmaceuticals will perform against the market?



You pick for Arrowhead Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chris Anzalone, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arrowhead Pharmaceuticals.

A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers